Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules

Immunology

Volumn 100, Issue 2, 2000, Pages 259-267

  Flo J ^a   Tisminetzky, S ^b   Baralle, F ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; DNA VACCINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; FEMALE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CELL CULTURE TECHNIQUES; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNIZATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0034044355     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00041.x     Document Type: Article

References (31)

1. 1. FYNAN E.F., WEBSTER R.G., FULLER D.H., HAYNES J.R., SANTORO J.C. & ROBINSON H.L. (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90, 11478.
2. 2. ULMER J.B., DONNELLY J.J., PARKER S.E. et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745.
3. 3. KIM J.J., BAGARAZZI M.L., TRIVEDI N. et al. (1997) Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat Biotechnol 15, 641.
4. 4. TSUJI T., HAMAJIMA K., ISHII N. et al. (1997) Immunomodulatory effects of a plasmid expressing B7-2 on human immunodeficiency virus-1-specific cell-mediated immunity induced by a plasmid encoding the viral antigen. Eur J Immunol 27, 782.
5. 5. TANG D.C., DE. VIT M. & JOHNSTON S.A. (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152.
6. 6. RAX E., CARSON D.A., PARKER S.E. et al. (1994) Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 91, 9519.
7. 7. HENGGE U.R., WALKER P.S. & VOGEL J.C. (1996) Expression of naked DNA in human, pig, and mouse skin. J Clin Invest 97, 2911.
8. 8. INABA K., WITMER-PACK M., INABA M. et al. (1994) The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro. J Exp Med 180, 1849.
9. 9. CAUX C., VANBERVLIET B., MASSACRIER C. et al. (1994) B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. J Exp Med 180, 1841.
10. 10. ENGEL P., GRIBBEN J., FREEMAN G. et al. (1994) The B7-2 (B70) costimulatory molecule expressed by monocytes and activated B lymphocytes is the CD86 differentiation antigen. Blood 84, 1402.
11. 11. SAMBROOK J., FRITSCH E.F. & MANIATIS T. (1982) Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
12. 12. PARR M.B., KEPPLE L., MCDERMOTT M.R., DREW M.D., BONZZOLA J.J. & PARR E.L. (1994) A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex type 2. Lab Invest 70, 369.
13. 13. OVERALL J.C., KERN E.R., SCHLITZER R.L., FRIEDMAN S.B. & GLASGOW L.A. (1975) Genital herpes virus infection in mice. I. Development of an experimental model. Infect Immun 11, 476.
14. 14. COHEN G.H., DIETZSCHOLD B., DE PONCE LEON M. et al. (1984) Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol 49, 102.
15. 15. NICOLA A.V., DE PONCE LEON M., XU R. et al. (1998) Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol 72, 3595.
16. 16. BLUESTONE J. (1995) New perspective of CD28-B7 mediated T cell costimulation. Immunity 2, 555.
17. 17. CONDON C., WATKINS S.C., CELLUZZI C.M., THOMPSON K. & FALO L.D. Jr (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2, 1122.
18. 18. LINSLEY P., GREENE J.B.W., BAJORATH J., LEDBETTER J. & PEACH R. (1994) Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity 1, 793.
19. 19. VAN DER MERWE P., BODIAN D., DAENKE S., LINSLEY P. & DAVIS S. (1997) CD80 (B7-1) binds both CD28 and CTLA-4 with low affinity and very fast kinetics. J Exp Med 185, 2515.
20. 20. LENSCHOW D., SU G.H.-T., ZUCKERMAN L. et al. (1993) Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci USA 90, 11054.
21. 21. HATHCOCK K., LASZLO G., PUCILLO C., LINSLEY P. & HODES R. (1994) Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function. J Exp Med 180, 631.
22. 22. GAJFWSKY T., FALLARINO F., UYTTENHOVE C. & BOON T. (1996) Tumor rejection requires a CTLA-4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J Immunol 156, 2909.
23. 23. MATULONIS U., DOSIOU C., FREEMAN G. et al. (1996) B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. Further evidence that B7-1 and B7-2 are functionally distinct. J Immunol 156, 1126.
24. 24. LENSCHOW D., WALUNAS T. & BLUESTONE J. (1996) CD28/B7 system of T cell costimulation. Annu Rev Immunol 14, 233.
25. 25. GREENFIELD E., HOWARD E., PARADIS T. et al. (1997) B7-2 expressed by T cells does not induce CD28-mediated costimulatory activity but retains CTLA-4 binding: implications for induction of antitumor immunity to T cell tumors. J Immunol 158, 2025.
26. 26. THOMPSON C. (1995) Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81, 979.
27. 27. KUCHROO V., DAS M., BROWN J.R.A. et al. (1995) B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathway: application to autoimmune disease therapy. Cell 80, 707.
28. 28. FREEMAN G.B.V., ANUMANTHAN A., BERNSTEIN G. et al. (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, as B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2, 523.
29. 29. PETRO T., CHEN S. & PANTHER R. (1995) Effect of CD80 and CD86 on T cell cytokine production. Immunol Invest 24, 965.
30. 30. LANIER L., O'FALLON S., SOMOZA C. et al. (1995) CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 154, 97.
31. 31. NATESAN M., RAZI-WOLI Z. & REISER H. (1996) Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J Immunol 156, 2783.